Free Trial
LON:PRTC

PureTech Health (PRTC) Share Price, News & Analysis

PureTech Health logo
GBX 155.40
+2.80 (+1.83%)
(As of 11/1/2024 ET)

About PureTech Health Stock (LON:PRTC)

Key Stats

Today's Range
152
160
50-Day Range
141.80
169.60
52-Week Range
138.75
238.50
Volume
768,531 shs
Average Volume
554,123 shs
Market Capitalization
£372.06 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule. It is also developing technology and products for screening, diagnosis, and treatment of neurological disorders, such as ADHD, autism, and depression through computer software; noninvasive neurostimulation treatment for psychiatric disorders; and combination therapy for schizophrenia. In addition, the company is developing drug delivery platform for oral administration of proteins, peptides, and other difficult-to-deliver payloads; products to generate new human hair follicles and hair; drug delivery platform for drugs that treat inflammation and associated disorders; platform to address immunosenescence; novel targeted immunotherapies for cancer; monoclonal antibodies for immuno-suppressive gamma delta T cells in pancreatic and colorectal cancers, and other solid tumors; novel approaches to enhance delivery and distribution of therapeutics; and digital health technologies, as well as engages in enhancing health through food through the creation of nutrition technology. Further, it is developing a platform and products that take in physiological data from sensors and correlates that data with musical data components; voice-based tools for passive assessment and tracking of patient health; commensal organism-based products for enhancing human health; and technology platform to identify experts in healthcare and other research-based disciplines, as well as engages in identifying healthcare expert networks and reviewing their conversations and content on social media. The company was incorporated in 2015 and is based in Boston, Massachusetts.

Receive PRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PureTech Health and its competitors with MarketBeat's FREE daily newsletter.

PRTC Stock News Headlines

Musk Says ‘Dollar Will Be Worth Nothing…’
Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…
See More Headlines

PRTC Stock Analysis - Frequently Asked Questions

PureTech Health's stock was trading at GBX 194.20 at the start of the year. Since then, PRTC stock has decreased by 20.0% and is now trading at GBX 155.40.
View the best growth stocks for 2024 here
.

Shares of PRTC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that PureTech Health investors own include IQE (IQE), Royal Dutch Shell (RDSB), BP (BP), GSK (GSK), Hummingbird Resources (HUM), Plug Power (PLUG) and AstraZeneca (AZN).

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
300
Year Founded
N/A

Profitability

Net Income
£-82,470,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£3.33 million
Cash Flow
GBX 72.56 per share
Book Value
GBX 132 per share

Miscellaneous

Free Float
N/A
Market Cap
£372.06 million
Optionable
Not Optionable
Beta
1.02
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (LON:PRTC) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners